glp-1 connecticut seeks approval to make generic alternative – NBC Connecticut With FDA approval of Wegovy

Offer is for 2 monthly fills through December 31, 2026, then $349 per month for Wegovy 0.25 mg, 0.5 mg, 1 mg, 1.7 mg or 2.4 mg and $399 per month for Wegovy HD (semaglutide) injection 7.2 mg

Semaglutide acts mainly at GLP-1 receptors, while tirzepatide acts at GIP and GLP-1 receptors

Storage, Formulation Vehicle, and the Blue Tint Copper peptides are more stable than many biological peptides, but proper storage of a GHK-Cu topical serum still matters for maintaining potency

Anti-inflammatory : Reduces inflammatory cytokines (TNF-alpha, IL-6), modulates immune response, protects tissues from damage

If you are very lean, your provider may recommend a 45-degree angle instead